Cost-effective strategies of testing for HIV and sexually transmitted infections (STIs)


  • Rates of chlamydia, gonorrhea, and infectious syphilis have risen in Canada from 2015 to 2019. An observed decrease in HIV cases has been detected recently, however a reduction in testing services throughout the COVID-19 pandemic may have impacted screening.
  • Cost-effective strategies for providing access to HIV/STI testing include self-testing at home, testing at sex venues, in emergency and non-emergency health care settings, in pharmacies, and using partner notification services. Evidence of cost-effectiveness was also found in strategies targeted to people experiencing homelessness or residing in detention centres.
  • Providing accessible, cost-effective HIV/STI testing has potential to reach individuals who have never received such screening before. Cost-effective HIV/STI screening can also provide financial benefits (i.e. reduced operational costs) to programs and facilities offering the services, such as hospitals and clinics.


The Ontario HIV Treatment Network: Rapid Response Service




  • Epidemiology and Determinants of Health
    • Determinants of Health
  • Determinants of Health
    • Health services
  • Population(s)
    • General HIV- population
  • Testing
    • Testing
  • Co-infections
    • Chlamydia
    • Gonorrhea
    • Syphilis
    • Other
  • Health Systems
    • Financial arrangements


Abstract/Full paper

Email 1 selected articles

Email 1 selected articles

Error! The email wasn't sent. Please try again.

Your email has been sent!